These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38573642)

  • 21. Immunotherapy for gastric premalignant lesions and cancer.
    Zorzetto V; Maddalo G; Basso D; Farinati F
    Immunotherapy; 2012 Jun; 4(6):587-99. PubMed ID: 22788127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy for gastric cancers: emerging role and future perspectives.
    Bonotto M; Garattini SK; Basile D; Ongaro E; Fanotto V; Cattaneo M; Cortiula F; Iacono D; Cardellino GG; Pella N; Fasola G; Antonuzzo L; Silvestris N; Aprile G
    Expert Rev Clin Pharmacol; 2017 Jun; 10(6):609-619. PubMed ID: 28349740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro experimental study on individualised immunotherapy induced by dendritic cells transfected with total RNA of autologous gastric cancer cells].
    Xie SJ; Yan QH; Shan BE; Fu ZX; Meng FJ; Li BD; Cai JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):92-5. PubMed ID: 16388755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer.
    Murphy AG; Kelly RJ
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):485-498. PubMed ID: 28501089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemotherapy and immunotherapy for gastric and colorectal cancer (author's transl)].
    Zeitoun P; Martin F
    Gastroenterol Clin Biol; 1978 May; 2(5):527-38. PubMed ID: 355039
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intratumoral injection of immature dendritic cells (DC) for cancer patients].
    Takeda T; Makita K; Okita K; Haba A; Xianhui D
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1574-5. PubMed ID: 16315873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for gastric diseases.
    Fumoto S; Nishi J; Nakamura J; Nishida K
    Curr Gene Ther; 2008 Jun; 8(3):187-200. PubMed ID: 18537593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splenectomy combined with gastrectomy and immunotherapy for advanced gastric cancer.
    Miwa H; Orita K
    Acta Med Okayama; 1983 Jun; 37(3):251-8. PubMed ID: 6880832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing immunotherapies to other frequently used treatments of gastric cancer.
    Basile D; Simionato F; Calvetti L; Cappetta A; Pesavento A; Mongillo M; Roviello G; Rosati G; Rossi G; Aprile G
    Expert Rev Clin Pharmacol; 2021 Oct; 14(10):1221-1232. PubMed ID: 34114518
    [No Abstract]   [Full Text] [Related]  

  • 30. [Surgical management of gastric cancer in the era of immunotherapy].
    Li ZY; Jia YN; Lu XX; Guan GM; Wang Q
    Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):353-358. PubMed ID: 38548601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudoprogression during immunotherapy for gastric adenocarcinoma: A case report and literature review.
    Zhang L; Tian T; Zhang Y; Yu S; Chen F; Qiao L; Hu P; Zhang J
    J Cancer Res Ther; 2023 Feb; 19(1):144-149. PubMed ID: 37006055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of Heparanase in Gastric Cancer Progression and Immunotherapy.
    Tang B; Yang S
    Adv Exp Med Biol; 2020; 1221():351-363. PubMed ID: 32274717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined treatment for gastric cancer: Immunological approach.
    Zhandossov O; Kaussova G; Koten A
    Turk J Gastroenterol; 2018 Mar; 29(2):151-156. PubMed ID: 29749320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular immunotherapy in gastric cancer: adoptive cell therapy and dendritic cell-based vaccination.
    Faghfuri E; Shadbad MA; Faghfouri AH; Soozangar N
    Immunotherapy; 2022 Apr; 14(6):475-488. PubMed ID: 35232264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell therapy in advanced gastric cancer: a promising new hope?
    Tewari M; Sahai S; Mishra RR; Shukla SK; Shukla HS
    Surg Oncol; 2012 Sep; 21(3):164-71. PubMed ID: 22521560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remnant gastric cancer: a neglected group with high potential for immunotherapy.
    Ramos MFKP; Pereira MA; de Castria TB; Ribeiro RRE; Cardili L; de Mello ES; Zilberstein B; Ribeiro-Júnior U; Cecconello I
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3373-3383. PubMed ID: 32671505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current treatment of gastric cancer: is adjuvant therapy of benefit?
    Lin JW; Leach SD
    Adv Surg; 2003; 37():95-121. PubMed ID: 12953629
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential role of rilotumumab in the treatment of gastric cancer.
    Waddell T; Moorcraft SY; Cunningham D
    Immunotherapy; 2014; 6(12):1243-53. PubMed ID: 25524381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model.
    Yu D; Yang J; Wang B; Li Z; Wang K; Li J; Zhu C
    Cancer Immunol Immunother; 2024 May; 73(6):112. PubMed ID: 38693422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adjuvant chemotherapy to gastric cancer and colonic cancer. Association with immunotherapy and carcinoembryonic antigen].
    Sachira ; Onda M; Tokunaga A; Kiyama T
    Nihon Ika Daigaku Zasshi; 1989 Dec; 56(6):622-4. PubMed ID: 2606952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.